0001104659-21-148677.txt : 20211210
0001104659-21-148677.hdr.sgml : 20211210
20211210170834
ACCESSION NUMBER: 0001104659-21-148677
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211208
FILED AS OF DATE: 20211210
DATE AS OF CHANGE: 20211210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yale Catriona
CENTRAL INDEX KEY: 0001779308
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38944
FILM NUMBER: 211486166
MAIL ADDRESS:
STREET 1: C/O AKERO THERAPEUTICS INC.
STREET 2: 170 HARBOR WAY 3RD FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001744659
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-487-6488
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
tm2135157-5_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-12-08
0
0001744659
Akero Therapeutics, Inc.
AKRO
0001779308
Yale Catriona
C/O AKERO THERAPEUTICS, INC.,
601 GATEWAY BOULEVARD, SUITE 350
SOUTH SAN FRANCISCO,
CA
94080
0
1
0
0
Chief Development Officer
Stock Option (Right to Buy)
21.1
2021-12-08
4
A
0
87221
0
A
2031-12-07
Common Stock
87221
87221
D
This option shall vest and become exercisable in 48 equal monthly installments commencing on December 8, 2021.
/s/ Jonathan Young, Attorney-in-fact
2021-12-10